Sanderson SD - Search Results

1

N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts.

Nishimori I, Perini F, Mountjoy KP, Sanderson SD, Johnson N, Cerny RL, Gross ML, Fontenot JD, Hollingsworth MA. Nishimori I, et al. Among authors: sanderson sd. Cancer Res. 1994 Jul 15;54(14):3738-44. Cancer Res. 1994. PMID: 8033093

2

Influence of acceptor substrate primary amino acid sequence on the activity of human UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferase. Studies with the MUC1 tandem repeat.

Nishimori I, Johnson NR, Sanderson SD, Perini F, Mountjoy K, Cerny RL, Gross ML, Hollingsworth MA. Nishimori I, et al. Among authors: sanderson sd. J Biol Chem. 1994 Jun 10;269(23):16123-30. J Biol Chem. 1994. PMID: 8206912 Free article.

3

The synthesis and compositional analysis of phosphopeptides.

Sanderson SD, Perini F. Sanderson SD, et al. Mol Biotechnol. 1995 Oct;4(2):139-49. doi: 10.1007/BF02921608. Mol Biotechnol. 1995. PMID: 8556429 Review.

4

T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1.

Pisarev VM, Kinarsky L, Caffrey T, Hanisch FG, Sanderson S, Hollingsworth MA, Sherman S. Pisarev VM, et al. Int Immunopharmacol. 2005 Feb;5(2):315-30. doi: 10.1016/j.intimp.2004.10.004. Int Immunopharmacol. 2005. PMID: 15652762

5

Molecular adjuvant effects of a conformationally biased agonist of human C5a anaphylatoxin.

Tempero RM, Hollingsworth MA, Burdick MD, Finch AM, Taylor SM, Vogen SM, Morgan EL, Sanderson SD. Tempero RM, et al. Among authors: sanderson sd. J Immunol. 1997 Feb 1;158(3):1377-82. J Immunol. 1997. PMID: 9013982

6

Phorbol ester stimulates phosphorylation on serine 1327 of the human insulin receptor.

Lewis RE, Volle DJ, Sanderson SD. Lewis RE, et al. Among authors: sanderson sd. J Biol Chem. 1994 Oct 21;269(42):26259-66. J Biol Chem. 1994. PMID: 7929343 Free article.

7

Decapeptide agonists of human C5a: the relationship between conformation and neutrophil response.

Sanderson SD, Kirnarsky L, Sherman SA, Vogen SM, Prakash O, Ember JA, Finch AM, Taylor SM. Sanderson SD, et al. J Med Chem. 1995 Sep 1;38(18):3669-75. doi: 10.1021/jm00018a028. J Med Chem. 1995. PMID: 7658455

8

NMR analysis of a potent decapeptide agonist of human C5a anaphylatoxin.

Vogen SM, Prakash O, Kirnarsky L, Sanderson SD, Sherman SA. Vogen SM, et al. Among authors: sanderson sd. J Pept Res. 1998 Mar;51(3):226-34. doi: 10.1111/j.1399-3011.1998.tb01220.x. J Pept Res. 1998. PMID: 9531426

9

Determination of structural elements related to the biological activities of a potent decapeptide agonist of human C5a anaphylatoxin.

Vogen SM, Prakash O, Kirnarsky L, Sanderson SD, Sherman SA. Vogen SM, et al. Among authors: sanderson sd. J Pept Res. 1999 Jul;54(1):74-84. doi: 10.1034/j.1399-3011.1999.00087.x. J Pept Res. 1999. PMID: 10448972

10

Role of polymorphonuclear leukocytes, nitric oxide synthase, and cyclooxygenase in vascular permeability changes induced by C5a agonist peptides.

Kurizaki T, Abe M, Sanderson SD, Enke CA, Baranowska-Kortylewicz J. Kurizaki T, et al. Among authors: sanderson sd. Mol Cancer Ther. 2004 Jan;3(1):85-91. Mol Cancer Ther. 2004. PMID: 14749478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters